PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Management of recurrent gastrointestinal cancer with ripretinib and surgery

Management of recurrent gastrointestinal cancer with ripretinib and surgery
2023-11-03
(Press-News.org)

“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.”

BUFFALO, NY- November 3, 2023 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.”

Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine kinase inhibitors.

In this new case report, researchers Mohamed A. Gouda, Filip Janku, Neeta Somaiah, Kelly K. Hunt, Sireesha Yedururi, and Vivek Subbiah from The University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute described the use of ripretinib in a patient with recurrent GIST harboring a KIT exon 11 mutation following treatment with multiple TKIs. The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.

“[...] we show the durable clinical benefit achieved in a patient with GIST by using ripretinib and repeated timely surgical resection of limited disease progression.”

A Hispanic female in her late 20s presented with left lower quadrant pain initially attributed to an ovarian cyst. A workup with computed tomography (CT) evaluation, revealed an incidental 6 cm duodenal mass with central necrosis. She underwent exploratory laparotomy with resection of the mass which was diagnosed as GIST with high malignant potential and positive immunohistochemistry for c-KIT. The total time on ripretinib was 43 months which is longer than the current reported data from ripretinib clinical trials. 

“Such an approach for using multi-disciplinary disease management can improve the durability of response to tyrosine kinase inhibitors, including ripretinib, and associated clinical outcomes.”

 

Read the full paper: DOI: https://doi.org/10.18632/oncoscience.586 

Correspondence to: Vivek Subbiah

Email: vivek.subbiah@scri.com 

Keywords: ripretinib, precision oncology, sarcoma, surgery
 

About Oncoscience: 

Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.

To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:

X, formerly known as Twitter  Facebook  YouTube  LinkedIn   

For media inquiries, please contact media@impactjournals.com.

 

Oncoscience Journal Office

6666 East Quaker Str., Suite 1D

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 4

###

END


[Attachments] See images for this press release:
Management of recurrent gastrointestinal cancer with ripretinib and surgery

ELSE PRESS RELEASES FROM THIS DATE:

Transforming the food system to serve all

2023-11-03
Health happens where people work, live, play and worship, says Prof. Stacey Snelling, chair of the Department of Health Studies in American University’s College of Arts and Sciences. And that’s where the Healthy Schools, Healthy Communities Lab engages children, adults and older adults to tackle health inequities. Snelling received a three-year grant of $2.8 million from Novo Nordisk Inc. for health education and to grow the number of Black farmers producing locally grown fruit and vegetables. The goal is to improve local ...

Oncology researchers raise ethics concerns posed by patient-facing Artificial Intelligence

2023-11-03
BOSTON – Ready or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies to schedule appointments, monitor their health, learn about their disease and its treatment, find support, and more. In a new paper in JCO Oncology Practice, bioethics researchers at Dana-Farber Cancer Institute call on medical societies, government leaders, clinicians, and researchers to work together to ensure AI-driven healthcare preserves patient autonomy and respects human dignity. The authors note that while AI has immense potential for expanding access to cancer care and improving the ...

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

2023-11-03
Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 2 in the Journal of Clinical Oncology. The radiopharmaceutical 225AC-J591 was administered in a single injection and consists of two parts: an antibody that helps find the cancer cells is linked to a molecule that delivers a deadly dose of radiation. Specifically, an antibody named J591 that ...

U of M-led study identifies new pathway to combat primary cause of cardiovascular disease

2023-11-03
MINNEAPOLIS/ST. PAUL (11/03/2023) — Research led by the University of Minnesota Medical School identified a new pathway to combat cardiovascular disease. The study was recently published in Nature Cardiovascular Research. The research team’s work identifies a molecule called TREM2 as a unique and therapeutically relevant pathway for the treatment of atherosclerosis—a common condition that develops when plaque builds up inside arteries—in preclinical models. Atherosclerosis is a primary cause of cardiovascular diseases, which are the number one ...

Illinois Tech grows research footprint, securing prime space at TCC’s Fulton Labs

Illinois Tech grows research footprint, securing prime space at TCC’s Fulton Labs
2023-11-03
CHICAGO—November 3, 2023—Illinois Institute of Technology (Illinois Tech) has leased approximately 34,295 square feet in Trammell Crow Company’s (TCC) Fulton Labs innovation hub, announced today by the Chicago office of TCC, a global real estate developer. Illinois Tech will occupy the entire 7th floor of the cutting-edge wet lab facilities at 400 North Aberdeen, aiming to fuel scientific breakthroughs and industry-relevant research as the first academic institution to join the thriving and collaborative innovation ecosystem alongside their Fulton Labs neighbors, which include Portal Innovations and the Chan Zuckerberg BioHub. ...

Physicists ask: Can we make a particle collider more energy efficient?

Physicists ask: Can we make a particle collider more energy efficient?
2023-11-03
Ever since the discovery of the Higgs boson in 2012, physicists have wanted to build new particle colliders to better understand the properties of that elusive particle and probe elementary particle physics at ever-higher energy scales. The trick is, doing so takes energy – a lot of it. A typical collider takes hundreds of megawatts – the equivalent of tens of millions of modern lightbulbs – to operate. That's to say nothing of the energy it takes to build the devices, and it all adds ...

Study shows that smoking ‘stops’ cancer-fighting proteins, causing cancer and making it harder to treat

2023-11-03
November 3, TORONTO — Scientists at the Ontario Institute for Cancer Research (OICR) have uncovered one way tobacco smoking causes cancer and makes it harder to treat by undermining the body’s anti-cancer safeguards. Their new study, published today in Science Advances, links tobacco smoking to harmful changes in DNA called ‘stop-gain mutations’ that tell the body to stop making certain proteins before they are fully formed. They found that these stop-gain mutations were especially prevalent in genes known as ‘tumour-suppressors’, ...

How salt from the Caribbean affects our climate

2023-11-03
Joint press release by MARUM - Center for Marine Environmental Sciences at the University of Bremen and GEOMAR Helmholtz Centre for Ocean Research Kiel The distribution of salt by ocean currents plays a crucial role in regulating the global climate. This is what researchers from Dalhousie University in Canada, GEOMAR Helmholtz Centre for Ocean Research Kiel, Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) and MARUM – Center for Marine Environmental Sciences at the University of Bremen have found in a new study. ...

Some benefits of exercise stem from the immune system

Some benefits of exercise stem from the immune system
2023-11-03
The connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race. Now, a new Harvard Medical School study published Nov. 3 in Science Immunology may offer a molecular explanation behind this century-old observation. The study, done in mice, suggests that the beneficial effects of exercise may be driven, at least partly, by the immune system. It shows that muscle inflammation caused by exertion mobilizes inflammation-countering T cells, or Tregs, which enhance the muscles’ ability to use ...

Seeing the unseen: How butterflies can help scientists detect cancer

Seeing the unseen: How butterflies can help scientists detect cancer
2023-11-03
There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth’s magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower frequencies than humans can. Butterflies can perceive a broader range of colors, including ultraviolet (UV) light. Inspired by the enhanced visual system of the Papilio xuthus butterfly, a team of researchers have developed an imaging sensor capable of “seeing” into the UV range inaccessible to human eyes. The design of the sensor uses stacked photodiodes and perovskite nanocrystals (PNCs) capable of imaging different wavelengths ...

LAST 30 PRESS RELEASES:

Oil rig study reveals vital role of tiny hoverflies

Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network

iRECODE: A new computational method that brings clarity to single-cell analysis

New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey

QUT scientists create material to turn waste heat into clean power

Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health

Cosmic crime scene: White dwarf found devouring Pluto-like icy world

Major report tackles Covid’s cardiovascular crisis head-on

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

Soccer headers and brain health: Study finds changes within folds of the brain

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

In the wild, chimpanzees likely ingest the equivalent of several alcoholic drinks every day

Warming of 2°C intensifies Arctic carbon sink but weakens Alpine sink, study finds

[Press-News.org] Management of recurrent gastrointestinal cancer with ripretinib and surgery